248 related articles for article (PubMed ID: 15782690)
1. [Three men with breast cancer].
Bergs EA; Tanis PJ; Steller EP
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
[TBL] [Abstract][Full Text] [Related]
2. Synchronous bilateral breast cancer in an aged male patient.
Yaman E; Ozturk B; Coskun U; Buyukberber S; Kaya AO; Yildiz R; Benekli M
Onkologie; 2010; 33(5):255-8. PubMed ID: 20502060
[TBL] [Abstract][Full Text] [Related]
3. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
[TBL] [Abstract][Full Text] [Related]
4. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer: experience from a Malaysian tertiary centre.
Ngoo KS; Rohaizak M; Naqiyah I; Shahrun Niza AS
Singapore Med J; 2009 May; 50(5):519-21. PubMed ID: 19495524
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative radiotherapy of the chest wall in patients with male breast cancer].
Zabel-du Bois A; Milker-Zabel S; Wannenmacher M; Debus J
Zentralbl Chir; 2007 Oct; 132(5):391-5. PubMed ID: 17907080
[TBL] [Abstract][Full Text] [Related]
9. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer in the male].
Diaconu C; Dogaru C; Coşman C; Livadariu R; Scarlat V; Miron L; Florea I; Bostaca T
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):428-33. PubMed ID: 20700980
[TBL] [Abstract][Full Text] [Related]
11. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
Cutuli B; Le-Nir CC; Serin D; Kirova Y; Gaci Z; Lemanski C; De Lafontan B; Zoubir M; Maingon P; Mignotte H; de Lara CT; Edeline J; Penault-Llorca F; Romestaing P; Delva C; Comet B; Belkacemi Y
Crit Rev Oncol Hematol; 2010 Mar; 73(3):246-54. PubMed ID: 19442535
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant systemic therapy for male breast carcinoma.
Giordano SH; Perkins GH; Broglio K; Garcia SG; Middleton LP; Buzdar AU; Hortobagyi GN
Cancer; 2005 Dec; 104(11):2359-64. PubMed ID: 16270318
[TBL] [Abstract][Full Text] [Related]
13. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
14. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
Boughey JC; Bedrosian I; Meric-Bernstam F; Ross MI; Kuerer HM; Akins JS; Giordano SH; Babiera GV; Ames FC; Hunt KK
J Am Coll Surg; 2006 Oct; 203(4):475-80. PubMed ID: 17000390
[TBL] [Abstract][Full Text] [Related]
18. [Clinical research advancement on male breast cancer].
Xue Y; Guo XT; Liu WC
Ai Zheng; 2007 Oct; 26(10):1148-52. PubMed ID: 17927890
[TBL] [Abstract][Full Text] [Related]
19. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
Goss PE
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
[TBL] [Abstract][Full Text] [Related]
20. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]